Ionic liquids （ILs） are green solvents that have attracted great attention in recent years due to their unique properties. In this paper the latest progresses in both the fundamental studies and applications of ILs ...Ionic liquids （ILs） are green solvents that have attracted great attention in recent years due to their unique properties. In this paper the latest progresses in both the fundamental studies and applications of ILs have been summarized, with the emphasis on the topics of physical properties, catalytic reactions, and biochemical engineering. The critical problems in the applications of the ILs have been addresses, and the prospective of the ILs were finally predicted.展开更多
Cancer is the second cause of death in Brazil and it is estimated that, for the year 2015, there would be about 576 new cases of cancer in the country, according to data of INCA （National Cancer Institute）. All canc...Cancer is the second cause of death in Brazil and it is estimated that, for the year 2015, there would be about 576 new cases of cancer in the country, according to data of INCA （National Cancer Institute）. All cancer patients who get chemotherapy for a longer period, at some time, will present a vascular peripheral fragility. The TIVAD （totally implanted venous access device）, also called ＂Port＂, is a good option for these patients since it facilitates a safe access for the treatment. The Port＇s permeability maintenance is done with a saline solution after any infusion and at the end of the infusion.展开更多
文摘Ionic liquids （ILs） are green solvents that have attracted great attention in recent years due to their unique properties. In this paper the latest progresses in both the fundamental studies and applications of ILs have been summarized, with the emphasis on the topics of physical properties, catalytic reactions, and biochemical engineering. The critical problems in the applications of the ILs have been addresses, and the prospective of the ILs were finally predicted.
文摘Cancer is the second cause of death in Brazil and it is estimated that, for the year 2015, there would be about 576 new cases of cancer in the country, according to data of INCA （National Cancer Institute）. All cancer patients who get chemotherapy for a longer period, at some time, will present a vascular peripheral fragility. The TIVAD （totally implanted venous access device）, also called ＂Port＂, is a good option for these patients since it facilitates a safe access for the treatment. The Port＇s permeability maintenance is done with a saline solution after any infusion and at the end of the infusion.
